Advanced Search

Study Preview



Study Title and Description

Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.



Key Questions Addressed
1 Is this a fiber intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.
Author Hartvigsen ML., Lærke HN., Overgaard A., Holst JJ., Bach Knudsen KE., Hermansen K.
Country Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.
Year 2014
Numbers Pubmed ID: 24595224

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber 5.0
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
Version 4.0
  • Comments Comments (
    0
    ) |
pubyear 2014
  • Comments Comments (
    0
    ) |
country Denmark
  • Comments Comments (
    0
    ) |
design Randomized Controlled Trial (Crossover)
  • Comments Comments (
    0
    ) |
blindness Single blind
  • Comments Comments (
    0
    ) |
diet Acute Feeding Study
  • Comments Comments (
    0
    ) |
feedcontrol All food provided
  • Comments Comments (
    0
    ) |
sampsize 15
  • Comments Comments (
    0
    ) |
runin No
  • Comments Comments (
    0
    ) |
washout Yes
  • Comments Comments (
    0
    ) |
dosechange No
  • Comments Comments (
    0
    ) |
age_adult 1
  • Comments Comments (
    0
    ) |
age_adol
  • Comments Comments (
    0
    ) |
age_child
  • Comments Comments (
    0
    ) |
age_baby
  • Comments Comments (
    0
    ) |
age_infant
  • Comments Comments (
    0
    ) |
age_oth
  • Comments Comments (
    0
    ) |
age_mean 63.5
  • Comments Comments (
    0
    ) |
age_range 52-73
  • Comments Comments (
    0
    ) |
bmi_mean 31.3
  • Comments Comments (
    0
    ) |
bmi_range 26.2-34.7
  • Comments Comments (
    0
    ) |
blhealth_healthy
  • Comments Comments (
    0
    ) |
blhealth_hyperlip
  • Comments Comments (
    0
    ) |
blhealth_diab
  • Comments Comments (
    0
    ) |
blhealth_hyperten
  • Comments Comments (
    0
    ) |
blhealth_digest
  • Comments Comments (
    0
    ) |
blhealth_met 1
  • Comments Comments (
    0
    ) |
blhealth_oth
  • Comments Comments (
    0
    ) |
blhealth_othspec
  • Comments Comments (
    0
    ) |
gender 53
  • Comments Comments (
    0
    ) |
ftype1 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip1_1 Arabinoxylan
  • Comments Comments (
    0
    ) |
descrip1_2 Arabinoxylan-oligosaccharides
  • Comments Comments (
    0
    ) |
dose1_1 3.5
  • Comments Comments (
    0
    ) |
dose1_2 0.8
  • Comments Comments (
    0
    ) |
duration1 1 day
  • Comments Comments (
    0
    ) |
admin1 Test meal
  • Comments Comments (
    0
    ) |
ftype2 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip2_1 Arabinoxylan
  • Comments Comments (
    0
    ) |
descrip2_2 Arabinoxylan-oligosaccharides
  • Comments Comments (
    0
    ) |
dose2_1 4.4
  • Comments Comments (
    0
    ) |
dose2_2 0.2
  • Comments Comments (
    0
    ) |
duration2 1 day
  • Comments Comments (
    0
    ) |
admin2 Test meal
  • Comments Comments (
    0
    ) |
ftype3 Combination/Mixture
  • Comments Comments (
    0
    ) |
descrip3_1 Arabinoxylan
  • Comments Comments (
    0
    ) |
descrip3_2 Arabinoxylan-oligosaccharides
  • Comments Comments (
    0
    ) |
dose3_1 4.7
  • Comments Comments (
    0
    ) |
dose3_2 0
  • Comments Comments (
    0
    ) |
duration3 1 day
  • Comments Comments (
    0
    ) |
admin3 Test meal
  • Comments Comments (
    0
    ) |
ftype4
  • Comments Comments (
    0
    ) |
descrip4_1
  • Comments Comments (
    0
    ) |
descrip4_2
  • Comments Comments (
    0
    ) |
dose4_1
  • Comments Comments (
    0
    ) |
dose4_2
  • Comments Comments (
    0
    ) |
duration4
  • Comments Comments (
    0
    ) |
admin4
  • Comments Comments (
    0
    ) |
comparator1 Low fiber control
  • Comments Comments (
    0
    ) |
cdose1 0.9
  • Comments Comments (
    0
    ) |
cduration1 1 day
  • Comments Comments (
    0
    ) |
cadmin1 Test meal
  • Comments Comments (
    0
    ) |
comparator2
  • Comments Comments (
    0
    ) |
cdose2
  • Comments Comments (
    0
    ) |
cduration2
  • Comments Comments (
    0
    ) |
cadmin2
  • Comments Comments (
    0
    ) |
comparator3
  • Comments Comments (
    0
    ) |
cdose3
  • Comments Comments (
    0
    ) |
cduration3
  • Comments Comments (
    0
    ) |
cadmin3
  • Comments Comments (
    0
    ) |
comparator4
  • Comments Comments (
    0
    ) |
cdose4
  • Comments Comments (
    0
    ) |
cduration4
  • Comments Comments (
    0
    ) |
cadmin4
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.